Insider Cluster (2 insiders) ·Filed Jul 8, 2026

UTHR

UNITED THERAPEUTICS Corp
NEUTRAL
Impact 2/10
Horizonimmediate Processed2mo ago
Insider cluster: 2 insiders, $236K total
Actionable Insight • Neutral

The insider selling is too small relative to market cap to warrant a bearish read. Monitor for any upcoming earnings release or guidance changes that could have prompted the selling, but given the routine pattern and strong analyst consensus, no immediate action is needed.

DirectionNeutral
Confidencehigh
Horizonimmediate
Final — all horizons settled through T+60d ⚠ clustered
UTHR ▲ +3.07% at T+60d
NEUTRAL call ✓ call won +3.07% · α vs SPY +0.58% · entry $554.34 → $571.38
Entry anchored
Jul 7, 03:59 PM ET
via exchange tick
T+1d
-0.34%
call -0.34% · α -1.18%
$552.48
settled 3mo ago
T+5d
-4.99%
call -4.99% · α -5.86%
$526.66
settled 3mo ago
T+20d
-6.81%
call -6.81% · α -10.08%
$516.58
settled 8w ago
T+60d
+3.07%
call +3.07% · α +0.58%
$571.38
settled 2d ago

Price Chart

Loading chart...

Executive Summary

CEO Martine Rothblatt sold ~$10.4M in open-market shares over two days (0.04% of market cap), alongside derivative exercises, and EVP Paul Mahon sold $125K. The selling is trivial relative to UTHR's $23.5B market cap, and likely reflects routine portfolio diversification or tax-related liquidity. No material signal for the stock.

Key Financial Metrics

Direction
selling
Total Value
$10.5M
Insiders
2

Key Facts

  • CEO Martine Rothblatt sold 18,694 open-market shares from July 6-7, 2026, totaling ~$10.4M.
  • CEO also exercised 28,500 derivative shares (with and without cash) during the same period.
  • EVP & General Counsel Paul Mahon sold 225 shares for $125K on July 2, 2026.
  • Total open-market selling in the cluster is ~$10.5M, representing only 0.045% of UTHR's $23.5B market cap.
  • All transactions are seller-initiated (code S) or derivative exercises (code M); no open-market buying occurred.
  • 82% of analysts rate UTHR as Buy or Strong Buy, and the stock has strong fundamentals.

Financial Impact

Total open-market sales of ~$10.5M, equivalent to 0.045% of market cap — negligible economic impact.

dilution (from derivative exercises)cash flow (non-material)

Risk Factors

  • CEO selling could be misinterpreted as a negative signal by less sophisticated market participants.
  • If the selling accelerates in future weeks beyond this pattern, it could signal a change in sentiment.

Market Snapshot

Exchange
Nasdaq
Sector
Pharmaceutical Preparations
Analyst Consensus
82% bullish (22 analysts)

Investment Themes

Biotech & Drug Discovery

Documents Analyzed

This report is based on 1 SEC document filed with EDGAR.

DocumentAccession Number
CLUSTER Data (Synthetic)cluster-UTHR-1783576915761
91 reports for UTHR
Performance horizon
80% Hit rate 4 of 5 directional calls best @ T+60▲ +5.53%Feb 25, 2026
Filters
Rows
Reports for UTHR — sortable, filterable
TypeNow
Sep 15, 2026
17d ago
Insider Cluster
NEUTRAL ★ 2/10
$500.35 $497.31▼ −0.61%▼ −2.72%$571.38 (+14.20%)
Sep 11, 2026
21d ago
Insider Cluster
NEUTRAL ★ 3/10
$497.11 $494.63▼ −0.50%▼ −0.28%$571.38 (+14.94%)
Sep 10, 2026
22d ago
Insider Cluster
MIXED ★ 4/10
$503.86 $497.27▼ −1.31%▼ −0.81%$571.38 (+13.40%)
Sep 9, 2026
23d ago
Insider Cluster
NEUTRAL ★ 3/10
$506.82 $498.48▼ −1.65%▼ −0.99%$571.38 (+12.74%)
Sep 4, 2026
28d ago
Insider Cluster
NEUTRAL ★ 2/10
$487.61 $502.70▲ +3.09%▲ +4.30%$571.38 (+17.18%)
Sep 3, 2026
29d ago
Insider Cluster
NEUTRAL ★ 2/10
$488.16 $497.11▲ +1.83%▲ +2.98%$571.38 (+17.05%)
Aug 28, 2026
5w ago
Insider Cluster
NEUTRAL ★ 2/10
$515.46 $487.61▼ −5.40%▼ −5.51%$571.38 (+10.85%)
Aug 27, 2026
5w ago
Insider Cluster
NEUTRAL ★ 2/10
$527.91 $492.02▼ −6.80%▼ −6.03%$571.38 (+8.23%)
Aug 26, 2026
5w ago
Insider Cluster
NEUTRAL ★ 3/10
$516.68 $492.02▼ −4.77%▼ −4.65%$571.38 (+10.59%)
Aug 25, 2026
5w ago
Insider Cluster
NEUTRAL ★ 2/10
$516.68 $492.02▼ −4.77%▼ −4.65%$571.38 (+10.59%)
Showing 10 of 91

US Market Status

Market Open — Closes in 6h 27m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access
Report published Jul 9, 2026